Coinfection With HIV and SARS-CoV-2 in Wuhan, China: A 12-Person Case Series
- 31 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 85 (1), 1-5
- https://doi.org/10.1097/QAI.0000000000002424
Abstract
Background: Given the magnitude of the global COVID-19 pandemic, persons living with HIV (PLWH) may become coinfected with SARS-CoV-2. Setting: We conducted a survey in Wuhan, China, to characterize the status of coinfected PLWH, their time to clinical improvement, and clinical prognoses. Methods: Using a Wuhan shipping service for antiretroviral medications, the Wuhan LGBT Center screened 2900 PLWH shipping addresses and cross-referenced 36 of them to quarantine sites or hospitals, suggesting possible COVID-19 cases. Through telephone calls and WeChat (social media) messaging, we conducted a survey after obtaining online informed consent. Results: We had 12 HIV-infected respondents (10 men and 2 women) who also reported COVID-19. The median age was 36 years (interquartile range: 33.0-56.3), mean age 42.4 years, and range 25-66 years of age. Nine of 10 persons on antiretroviral therapy (ART) presented with only mild COVID-19 symptoms. The 10th person on ART was a 56-year-old man who died at home early in the outbreak when health care services were overwhelmed. Two additional cases who had been in intensive care with acute COVID-19 were both men, aged 25 and 37 years; both were ART-naive until this hospitalization. Excluding the deceased man, 6 of 11 coinfected persons reported feeling depressed even after clinical improvements. Conclusion: Twelve coinfected persons were identified in Wuhan; 9 of 10 were on long-term ART and had favorable outcomes. Two men identified as having started ART only recently were found to have severe symptoms. Our case series suggests the value of ART for potential mitigation of COVID-19 coinfection.Keywords
This publication has 17 references indexed in Scilit:
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19New England Journal of Medicine, 2020
- COVID-19 in patients with HIV: clinical case seriesThe Lancet HIV, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJama-Journal Of The American Medical Association, 2020
- Keep older healthcare workers off the covid-19 front lineBMJ, 2020
- Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C VirusClinical Infectious Diseases, 2020
- How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV ResearchAIDS and Behavior, 2020
- Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang HospitalClinical Microbiology & Infection, 2020
- Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessmentJournal of the International AIDS Society, 2020
- Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, ChinaJournal of Medical Virology, 2020
- Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed HIV-infected Chinese MSMAIDS, 2017